LEUKEMIA

Advances in Monitoring Minimal Residual Leukemia
CAMPANA, Dario, MD PhD
Professor and Vice Chair for Laboratory Research,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

P53-Associated Childhood Malignancies
RIBEIRO, Raul MD
Professor and Director, Division of Leukemia/Lymphoma,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Tailored Therapy in T Cell ALL
SCHRAPPE, Martin, MD
Chair of General Pediatrics
University Hospital Schleswig-Holstein
Campus Kiel
Kiel, GERMANY

Treatment of High Risk ALL
PUI, Ching-Hon MD
American Cancer Society Professor and Chair, Department of Oncology,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

ALL – The COG Experience
LOH, Mignon, MD
Assistant Clinical Professor of Pediatrics
University of California San Francisco
Clinical Cancer Specialist
University of California San Francisco Medical Center
San Francisco, California, USA

An Update on Leukemia Treatment in High and Low Income Countries
VEERMAN, Anjo, MD
Emeritus Professor of Pediatrics, Vrije Universiteit,
Amsterdam, The NETHERLANDS
Visiting Professor of Pediatrics, Gadjah Mada University,
Jogjakarta, INDONESIA

Highlights in Supportive Care for Children with ALL
HOWARD, Scott, MD, MS.
Medical Information Officer; Director of Clinical Trials, International Outreach Program; Associate
Professor, University of Tennessee College of Medicine
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

LYMPHOMA

Treatment of Non-Hodgkin’s Lymphoma in Children and Adolescents – Current Experience and Future Directions
REITER, Alfred, MD
Professor of Pediatric Hematology and Oncology
Justus-Liebig-University
Director of the Division of Pediatric Hematology and Oncology
Children’s University Hospital
Giessen, GERMANY

MYELODYSPLASTIC SYNDROME AND JMML

Cytogenetics in Childhood MDS
SCHLEGELBERGER, Brigitte, MD
Head
Institute of Cell and Molecular Pathology
Hannover Medical School
Hannover, GERMANY

Recent Advances in JMML
LOH, Mignon, MD
Assistant Clinical Professor of Pediatrics
University of California San Francisco
Clinical Cancer Specialist
University of California San Francisco Medical Center
San Francisco, California, USA

Solid Tumors

New Concepts in the Treatment of Retinoblastoma
RODRIGUEZ-GALINDO Carlos, MD
Lecturer, Department of Pediatrics, Harvard Medical School
Director, Solid Tumor Program, Pediatric Oncology, Dana-Farber Cancer Institute
Medical Director, Pediatric Oncology Clinical Trials, Pediatric Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, USA